Stock Research for SLP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SLP Stock Chart & Research Data

The SLP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SLP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SLP Due diligence Resources & Stock Charts

The SLP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SLP Detailed Price Forecast - CNN Money CNN View SLP Detailed Summary - Google Finance
Yahoo View SLP Detailed Summary - Yahoo! Finance Zacks View SLP Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View SLP Trends & Analysis - Trade-Ideas Barrons View SLP Major Holders - Barrons
NASDAQ View SLP Call Transcripts - NASDAQ Seeking View SLP Breaking News & Analysis - Seeking Alpha
Spotlight View SLP Annual Report - CompanySpotlight.com OTC Report View SLP OTC Short Report - OTCShortReport.com
TradeKing View SLP Fundamentals - TradeKing Charts View SLP SEC Filings - Bar Chart
WSJ View Historical Prices for SLP - The WSJ Morningstar View Performance/Total Return for SLP - Morningstar
MarketWatch View the Analyst Estimates for SLP - MarketWatch CNBC View the Earnings History for SLP - CNBC
StockMarketWatch View the SLP Earnings - StockMarketWatch MacroAxis View SLP Buy or Sell Recommendations - MacroAxis
Bullish View the SLP Bullish Patterns - American Bulls Short Pains View SLP Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View SLP Stock Mentions - StockTwits PennyStocks View SLP Stock Mentions - PennyStockTweets
Twitter View SLP Stock Mentions - Twitter Invest Hub View SLP Investment Forum News - Investor Hub
Yahoo View SLP Stock Mentions - Yahoo! Message Board Seeking Alpha View SLP Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for SLP - SECform4.com Insider Cow View Insider Transactions for SLP - Insider Cow
CNBC View SLP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SLP - OTC Markets
Yahoo View Insider Transactions for SLP - Yahoo! Finance NASDAQ View Institutional Holdings for SLP - NASDAQ


Stock Charts

FinViz View SLP Stock Insight & Charts - FinViz.com StockCharts View SLP Investment Charts - StockCharts.com
BarChart View SLP Stock Overview & Charts - BarChart Trading View View SLP User Generated Charts - Trading View


Latest Financial News for SLP

Simulations Plus to Present at the 8th Annual LD Micro Invitational Investor Conference on June 5, 2018
Posted on Friday June 01, 2018

Simulations Plus, Inc. , the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, and chemical industries, today announced that it will participate in the 8th Annual LD Micro Invitational Investor Conference to be held at the Luxe Sunset Boulevard Hotel in Los Angeles.


Simulations Plus Releases GastroPlus™ Version 9.6
Posted on Wednesday May 23, 2018

Simulations Plus, Inc. (SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has released version 9.6 of its flagship PBPK modeling program, GastroPlus™. With the ever-increasing emphasis on PBPK modeling from regulatory agencies globally, the client base for GastroPlus continues to expand.


Is Simulations Plus Inc’s (NASDAQ:SLP) ROE Of 28.61% Sustainable?
Posted on Friday May 18, 2018

Simulations Plus Inc (NASDAQ:SLP) outperformed the Health Care Technology industry on the basis of its ROE – producing a higher 28.61% relative to the peer average of 15.28% over theRead More...


Simulations Plus to Present at the Needham Emerging Technology Conference on May 16, 2018
Posted on Tuesday May 15, 2018

Simulations Plus, Inc. (SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today announced that chairman and chief executive officer, Walt Woltosz, will present at the Needham Emerging Technology Conference on Wednesday, May 16, 2018, at 3:00 p.m. ET and will conduct one-on-one meetings throughout the day. Simulations Plus, Inc. is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents.


Enter a stock symbol to view the stock details.